Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Medical Data Vision Co.Ltd. ( (JP:3902) ) has issued an update.
Medical Data Vision Co., Ltd. reported its consolidated financial results for the first quarter of 2025, showing a 10.4% increase in net sales compared to the previous year. However, the company experienced a significant decline in operating income by 67.6%, which may impact its financial stability and investor confidence. Despite the challenges, the company maintains a strong equity-to-asset ratio of 60.4%, indicating a stable financial position. The forecast for the fiscal year ending December 31, 2025, anticipates a substantial increase in net sales by 52.4%, suggesting potential growth opportunities.
More about Medical Data Vision Co.Ltd.
Medical Data Vision Co., Ltd. operates in the healthcare industry, focusing on providing data solutions and analytics services. The company is listed on the Tokyo Stock Exchange and is known for its efforts in leveraging medical data to enhance healthcare services.
Average Trading Volume: 198,714
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen16.65B
Find detailed analytics on 3902 stock on TipRanks’ Stock Analysis page.